Dr. Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Mount Auburn St
Cambridge, MA 02138Phone+1 617-499-5054Fax+1 617-499-5465
Education & Training
- Massachusetts General HospitalFellowship, Consultation-Liaison Psychiatry, 2009 - 2010
- Boston University Medical CenterResidency, Psychiatry, 2005 - 2009
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005
Certifications & Licensure
- MA State Medical License 2007 - 2026
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Consultation-Liaison Psychiatry
Clinical Trials
- Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL Start of enrollment: 2020 Dec 15
Publications & Presentations
PubMed
- 240 citationsIdelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicityBenjamin L. Lampson, Siddha Kasar, Tiago R. Matos, Elizabeth A. Morgan, Laura Z. Rassenti
Blood. 2016-07-14 - 44 citationsTargeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.Cody Paiva, J C Godbersen, Allison Berger, Jennifer R. Brown, Alexey V. Danilov
Cell Death & Disease. 2015-07-09 - 13 citationsRelapsed CLL: sequencing, combinations, and novel agents.Jennifer R. Brown
Hematology. American Society of Hematology. Education Program. 2018-11-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: